Psychemedics Corporation (PMD) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Psychemedics Corporation (PMD)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.67

0.00 (0.00%)

At close: Dec 12, 2024, 9:00 PM

undefined% (undefined)

Bid	2.37
Market Cap	15.74M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.51
PE Ratio (ttm)	-5.24
Forward PE	n/a
Analyst	n/a

Ask	2.5
Volume	112,269
Avg. Volume (20D)	44,097
Open	2.60
Previous Close	2.67
Day's Range	2.60 - 2.67
52-Week Range	1.11 - 3.95
Beta	undefined

About PMD

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine;...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jan 22, 1987

Employees 116

Stock Exchange NASDAQ

Ticker Symbol PMD

Website https://www.psychemedics.com

Why Price Moved

5 months ago · Source

Psychemedics shares are trading higher after the c... Unlock content with Pro Subscription

News

2 years ago · seekingalpha.com

Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play

21% YoY revenue growth in Q4, gross margins surge 1,000 bps YoY. EPS loss of $0.29 on higher legal costs and a one-time expense.

3 years ago · seekingalpha.com

Small And Microcap Newsletter: DHT Holdings Financials Give It Time Until The Next Tanker Bull Market

In this week's newsletter, we look at a company in the middle of monetizing its major asset to see what is left after the deal closes. We also review a shipping company that has built a strong margin ...

3 years ago · seekingalpha.com

Psychemedics: Q3 Revenues +29%, Margins Surge, Possible Corporate Actions Including Dividend

29% YoY revenue growth in Q3, margins surge.

3 years ago · seekingalpha.com

Psychemedics: Market Leader, 8% FCF Yield, Possible Takeover Target

Market-leading drug testing company, 30 years history, drug abuse increasing in the US. 13x P/E, 8% FCF yield on “normal” 2023 estimates.

3 years ago · businesswire.com

Montana Advisors Writes Open Letter to Psychemedics

MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time...